AMELX and craniopharyngioma: This study investigated the immunohistochemical expression of amelogenin (AMELX), odontogenic ameloblast-associated protein (ODAM), and cytokeratin 19 (CK19) in craniopharyngioma and ameloblastoma, aiming to shed light on their potential shared embryological origins and divergent pathological mechanisms.